<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>The Regeneration Station</title>
	<atom:link href="http://regeneration-station.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://regeneration-station.com</link>
	<description>Stem cells, biomaterials, engineered tissues, and other cell-based technologies.  The guts of the Regenerative Medine industry.</description>
	<pubDate>Sat, 08 Mar 2008 04:29:03 +0000</pubDate>
	<generator>http://wordpress.org/?v=MU</generator>
	<language>en</language>
			<item>
		<title>Takin&#8217; a short blog break</title>
		<link>http://regeneration-station.com/2008/03/01/takin-a-short-blog-break/</link>
		<comments>http://regeneration-station.com/2008/03/01/takin-a-short-blog-break/#comments</comments>
		<pubDate>Sat, 01 Mar 2008 16:53:46 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
		
		<category><![CDATA[Regenerative Medicine]]></category>

		<category><![CDATA[twitter experimentation]]></category>

		<category><![CDATA[intermission]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/?p=104</guid>
		<description><![CDATA[Currently, I am in the middle of moving my family to Frederick, Maryland.  I am starting a new position at Lonza, and it may take a couple weeks to figure out how the blog fits with the new position/company.
Please stay tuned, and I should be able to start back up in one form or [...]]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/03/01/takin-a-short-blog-break/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/jrowley-128.jpg" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>
	</item>
		<item>
		<title>Q Therapeutics&#8217; and Invitrogen&#8217;s Symbiotic Relationship</title>
		<link>http://regeneration-station.com/2008/02/25/q-therapeutics-and-invitrogens-symbiotic-relationship/</link>
		<comments>http://regeneration-station.com/2008/02/25/q-therapeutics-and-invitrogens-symbiotic-relationship/#comments</comments>
		<pubDate>Mon, 25 Feb 2008 03:05:26 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
		
		<category><![CDATA[Bioprocessing]]></category>

		<category><![CDATA[Clinical Trials]]></category>

		<category><![CDATA[Company Profiles]]></category>

		<category><![CDATA[MS]]></category>

		<category><![CDATA[Manufacturing]]></category>

		<category><![CDATA[Neural Repair]]></category>

		<category><![CDATA[Q Therapeutics]]></category>

		<category><![CDATA[Regenerative Medicine]]></category>

		<category><![CDATA[adult stem cell]]></category>

		<category><![CDATA[stem cells]]></category>

		<category><![CDATA[symbiotic business relationships]]></category>

		<category><![CDATA[cell therapy tools]]></category>

		<category><![CDATA[cell therapy development]]></category>

		<category><![CDATA[GMP-grade kits and reagents]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/?p=97</guid>
		<description><![CDATA[Q Therapeutics, a cell therapy company focusing on neural applications, recently announced a $15M series B financing that included funding from multiple venture capital (VC) groups as well as biotech tools provider Invitrogen.  Q&#8217;s lead product, Q-Cells™, is an allogeneic product intended to restore function to damaged neurons by providing trophic (e.g. cytokines, growth [...]]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/02/25/q-therapeutics-and-invitrogens-symbiotic-relationship/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/jrowley-128.jpg" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/02/logo.jpg" medium="image">
			<media:title type="html">logo.jpg</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/02/img.jpg" medium="image">
			<media:title type="html">img.jpg</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/02/invitrogenlogo.gif" medium="image">
			<media:title type="html">invitrogenlogo.gif</media:title>
		</media:content>
	</item>
		<item>
		<title>New Vascular Closure Devices Aim to Gain Bigger Piece of Endovascular Device Market</title>
		<link>http://regeneration-station.com/2008/02/24/new-vascular-closure-devices-aim-to-gain-bigger-piece-of-endovascular-device-market/</link>
		<comments>http://regeneration-station.com/2008/02/24/new-vascular-closure-devices-aim-to-gain-bigger-piece-of-endovascular-device-market/#comments</comments>
		<pubDate>Sun, 24 Feb 2008 01:44:44 +0000</pubDate>
		<dc:creator>shsiong</dc:creator>
		
		<category><![CDATA[AccessClosure]]></category>

		<category><![CDATA[Biomaterials]]></category>

		<category><![CDATA[Datascope]]></category>

		<category><![CDATA[NeoMend]]></category>

		<category><![CDATA[PEG-based Biomaterials]]></category>

		<category><![CDATA[St. Jude Medical]]></category>

		<category><![CDATA[Vascular Closure]]></category>

		<category><![CDATA[biomaterial devices]]></category>

		<category><![CDATA[vascular regeneration]]></category>

		<category><![CDATA[catheterization]]></category>

		<category><![CDATA[endovascular]]></category>

		<category><![CDATA[Mynx]]></category>

		<category><![CDATA[ProGEL]]></category>

		<category><![CDATA[vascular closure devices]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/?p=99</guid>
		<description><![CDATA[ by Susan Hsiong, PhD










 More than 12 million minimally invasive vascular surgeries are done every year.  These                                     [...]]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/02/24/new-vascular-closure-devices-aim-to-gain-bigger-piece-of-endovascular-device-market/feed/</wfw:commentRss>
	
		<media:content url="http://www.accessclosure.com/media/images/accessClosure%5Flogo.gif" medium="image" />

		<media:content url="http://www.neomendinc.com/images/neomend_02.gif" medium="image" />
	</item>
		<item>
		<title>The Developing Embyronic Stem Cell Clinical Landscape</title>
		<link>http://regeneration-station.com/2008/02/14/the-developing-embyronic-stem-cell-clinical-landscape/</link>
		<comments>http://regeneration-station.com/2008/02/14/the-developing-embyronic-stem-cell-clinical-landscape/#comments</comments>
		<pubDate>Thu, 14 Feb 2008 11:37:07 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
		
		<category><![CDATA[Advanced Cell Technology]]></category>

		<category><![CDATA[Athersys]]></category>

		<category><![CDATA[Clinical Trials]]></category>

		<category><![CDATA[Cytori]]></category>

		<category><![CDATA[Embyonic Stem Cells]]></category>

		<category><![CDATA[FDA]]></category>

		<category><![CDATA[Geron]]></category>

		<category><![CDATA[JNJ]]></category>

		<category><![CDATA[Novocell]]></category>

		<category><![CDATA[Osiris]]></category>

		<category><![CDATA[Regenerative Medicine]]></category>

		<category><![CDATA[adult stem cell]]></category>

		<category><![CDATA[spinal cord injury]]></category>

		<category><![CDATA[stem cells]]></category>

		<category><![CDATA[embryonic vs adult stem cell]]></category>

		<category><![CDATA[embyryonic stem cell 2008]]></category>

		<category><![CDATA[evolving clinical landscape]]></category>

		<category><![CDATA[safety issues]]></category>

		<guid isPermaLink="false">http://regenerationstation.wordpress.com/?p=93</guid>
		<description><![CDATA[ES cell biopsy from blastocyst.  ]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/02/14/the-developing-embyronic-stem-cell-clinical-landscape/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/jrowley-128.jpg" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/02/es-cell-biopsy.thumbnail.jpg" medium="image">
			<media:title type="html">es-cell-biopsy.jpg</media:title>
		</media:content>
	</item>
		<item>
		<title>Geron Bolsters Extensive Embryonic Stem Cell Patent Estate</title>
		<link>http://regeneration-station.com/2008/02/07/geron-bolsters-extensive-embryonic-stem-cell-patent-estate/</link>
		<comments>http://regeneration-station.com/2008/02/07/geron-bolsters-extensive-embryonic-stem-cell-patent-estate/#comments</comments>
		<pubDate>Thu, 07 Feb 2008 13:48:07 +0000</pubDate>
		<dc:creator>jrowley</dc:creator>
		
		<category><![CDATA[Embyonic Stem Cells]]></category>

		<category><![CDATA[Geron]]></category>

		<category><![CDATA[Intellectual Property]]></category>

		<category><![CDATA[Novocell]]></category>

		<category><![CDATA[Regenerative Medicine]]></category>

		<category><![CDATA[Type 1 diabetes]]></category>

		<category><![CDATA[culture conditions]]></category>

		<category><![CDATA[embryonic germ cells]]></category>

		<category><![CDATA[endoderm]]></category>

		<category><![CDATA[patent protection]]></category>

		<guid isPermaLink="false">http://regeneration-station.com/?p=85</guid>
		<description><![CDATA[Geron yesterday announced the issuance of US patent #7,326,572, helping to extend their patent protection around their embryonic stem (ES) cell platform technology in the area of treating type 1 diabetes.  Currently, Geron owns an exclusive license from the Wisconsin Alumni Research Foundation (WARF) for James Tomson&#8217;s original ES patents.  This license allows [...]]]></description>
		<wfw:commentRss>http://regeneration-station.com/2008/02/07/geron-bolsters-extensive-embryonic-stem-cell-patent-estate/feed/</wfw:commentRss>
	
		<media:content url="http://a.wordpress.com/avatar/jrowley-128.jpg" medium="image">
			<media:title type="html">jrowley</media:title>
		</media:content>

		<media:content url="http://regenerationstation.files.wordpress.com/2008/02/es-pic.png" medium="image">
			<media:title type="html">es-pic.png</media:title>
		</media:content>
	</item>
	</channel>
</rss>